Ani Pharmaceuticals ANIP
NASDAQ ANIP
$67.79 +0.38 (+0.56%)
At close: Nov 9, 2026 · 4:00 PM EST

Ani Pharmaceuticals (ANIP) Shares Outstanding (Diluted) (2010 - 2026)

Updated

Ani Pharmaceuticals' Weighted Average Shares Outstanding (Diluted) came in at 21.92 million for Q2 2026, up 7.9% from 20.31 million a year earlier and up 1.7% from the prior quarter.

Analysis

Ani Pharmaceuticals (ANIP) Shares Outstanding (Diluted) (2010 - 2026) Analysis & Trends

For FY2025, Ani Pharmaceuticals' Weighted Average Shares Outstanding (Diluted) was 21.23 million, up 9.9% from FY2024.

  • Weighted Average Shares Outstanding (Diluted) has increased in each of the last five years, with a five-year compound annual growth rate of 12.2% (FY2020 to FY2025).
  • Going back by year, Weighted Average Shares Outstanding (Diluted) was 19.32 million in FY2024 (+6.2%), 18.19 million in FY2023 (+11.9%), 16.26 million in FY2022 (+29.1%) and 12.6 million in FY2021 (+5.3%).
  • The Q2 2026 figure represents the highest quarterly Weighted Average Shares Outstanding (Diluted) in data going back to Q2 2010.
  • Year-over-year, Weighted Average Shares Outstanding (Diluted) has increased for 22 consecutive quarters, with growth averaging 6.2% over the last eight quarters.
  • The year-over-year growth in Weighted Average Shares Outstanding (Diluted) has ranged between 0.9% (Q3 2021) and 34.7% (Q3 2022) over the last five years.
  • Business Quant data shows ANIP's Weighted Average Shares Outstanding (Diluted) at 21.54 million (Q1 2026), 21.23 million (Q4 2025) and 21.09 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 893.40 Mn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 2.45 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 1.77 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 2.48 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn - 1.96 Bn
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 1.56 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 546.00 Mn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 1.25 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 5.75 Bn
10 Ani Pharmaceuticals 1.43 Bn 212.92 Mn 165.89 Mn 21.92 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.92 Mn
Mar 31, 2026 21.54 Mn
Dec 31, 2025 21.23 Mn
Sep 30, 2025 21.09 Mn
Jun 30, 2025 20.31 Mn
Mar 31, 2025 20.05 Mn
Dec 31, 2024 19.32 Mn
Sep 30, 2024 19.40 Mn
Jun 30, 2024 19.32 Mn
Mar 31, 2024 19.42 Mn
Dec 31, 2023 18.19 Mn
Sep 30, 2023 19.13 Mn
Jun 30, 2023 17.86 Mn
Mar 31, 2023 16.53 Mn
Dec 31, 2022 16.26 Mn
Sep 30, 2022 16.30 Mn
Jun 30, 2022 16.27 Mn
Mar 31, 2022 16.14 Mn
Dec 31, 2021 12.60 Mn
Sep 30, 2021 12.11 Mn
API Access

Ani Pharmaceuticals Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=ANIP&period=max&api_key=YOUR_API_KEY